Tiludronic acid is a bisphosphonate used for treatment of Paget's disease of bone
(osteitis deformans) in human medicine. It has the tradename Skelid.
Tiludronate is a bisphosphonate characterized by a (4-chlorophenylthio) group
on the carbon atom of the basic P-C-P structure common to all bisphosphonates.
Tiludronate is used to treat Paget's disease of bone (a condition in which the
bones are soft and weak and may be deformed, painful, or easily broken).
Easy to read patient leaflet for tiludronate. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Drug information on Skelid (tiludronate), includes drug pictures, side effects, drug
interactions, directions for use, symptoms of overdose, and what to avoid.
(molecular weight 380.6). SKELID tablets for oral administration contain 240 mg
tiludronate disodium, which is the molar equivalent of 200 mg tiludronic acid.
Tiludronate is a compound in the bisphosphonate class of drugs. ... Tildren, an
injectable form of tiludronate made for the horse, has been licensed to treat ...
REASONS FOR PERFORMING STUDY: Tiludronate regulates bone remodelling
through a decrease of the resorptive process and should therefore ameliorate ...
Am J Vet Res. 2007 Mar;68(3):329-37. Efficacy of tiludronate in the treatment of
horses with signs of pain associated with osteoarthritic lesions of the ...
Tiludronic Acid | C7H9ClO6P2S | CID 60937 - structure, chemical names,
physical and chemical properties, classification, patents, literature, biological